Masafumi Kitakaze

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Topics

Left Ventricular

Top Venues

Nature medicine

Cardiovascular drugs and therapy

American journal of physiology. Heart and circulatory physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Shin Ito, Yuri Nakajima, Hiroki Fukuda, Chisato Izumi, Gaku Nakazawa, Hajime Yamashita, Hideo Matsuhisa, Moriaki Inoko, Shigeru Toyoda, Shin Takiuchi, Toru Kataoka, Yasuhiro Izumiya, Yukio Abe, Takashi Sozu, Yasushi Sakata, Masanori Emoto, Teruo Inoue, Masafumi Kitakaze
Rationale and Design of Prospective, Multicenter, Double-Arm Clinical Trial to Investigate the Efficacy of Tofogliflozin on Left Ventricular Diastolic Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus (TOP-HFPEF Trial). Cardiovascular drugs and therapy (2024)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine (2023)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine (2023)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Hiroshi Asanuma, Masafumi Kitakaze
Is Aspirin Loading Before Primary Percutaneous Coronary Intervention for Patients with ST-Elevation Myocardial Infarction Necessary? Cardiovascular drugs and therapy 36 (6) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Kazuhiro Shindo, Hiroki Fukuda, Tatsuro Hitsumoto, Shin Ito, Jiyoong Kim, Takashi Washio, Masafumi Kitakaze
Plasma BNP Levels and Diuretics Use as Predictors of Cardiovascular Events in Patients with Myocardial Infarction and Impaired Glucose Tolerance. Cardiovascular drugs and therapy 34 (1) (2020)
Kazuhiro Shindo, Hiroki Fukuda, Tatsuro Hitsumoto, Yohei Miyashita, Jiyoong Kim, Shin Ito, Takashi Washio, Masafumi Kitakaze
Artificial Intelligence Uncovered Clinical Factors for Cardiovascular Events in Myocardial Infarction Patients with Glucose Intolerance. Cardiovascular drugs and therapy 34 (4) (2020)
Irving H Zucker, Merry L Lindsey, Mario Delmar, Leon J De Windt, Christine Des Rosiers, Debra I Diz, Robert L Hester, Steven R Jones, Nancy L Kanagy, Masafumi Kitakaze, Ronglih Liao, Gary D Lopaschuk, Kaushik P Patel, Fabio A Recchia, Junichi Sadoshima, Ajay M Shah, Zoltan Ungvari, Ivor J Benjamin, Mordecai P Blaustein, Nisha Charkoudian, Igor R Efimov, David Gutterman, David A Kass, Yulin Liao, Donal S O'Leary, Crystal M Ripplinger, Michael S Wolin
Why publish in the American Journal of Physiology-Heart and Circulatory Physiology? American journal of physiology. Heart and circulatory physiology 313 (2) (2017)
Hiroyuki Takahama, Masafumi Kitakaze
Pathophysiology of cardiorenal syndrome in patients with heart failure: potential therapeutic targets. American journal of physiology. Heart and circulatory physiology 313 (4) (2017)
Osamu Tsukamoto, Masafumi Kitakaze
Radiation-induced HFpEF model as a potential tool for the exploration of novel therapeutic targets. American journal of physiology. Heart and circulatory physiology 313 (2) (2017)